daewoong pharmaceutical 069620 Algorithm Investment Report

1. Performance Analysis of Algorithm (consolidated) 069620 Date
Period 3 months 100-m won
2018.12 2019.12 2020.12 Average 2020.06 2020.09 2020.12 2021.03 2021.06 2021.09
IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con)
Sales 10,314 11,134 10,554 10,667 2,539 2,768 2,672 2,696 2,727 2,758 2,669
O-profit 276 447 170 298 -32 59 87 226 594 1,562 85
N-income -154 289 241 125 -35 33 214 -209 -587 -1,647 1
O-rate 2.7 4.0 1.6 2.8 -1.3 2.1 3.3 8.4 21.8 56.6 3.1
N-rate -1.5 2.6 2.3 1.1 -1.4 1.2 8.0 -7.8 -21.5 -59.7 0.0
ROE -2.5 4.5 3.5 1.8 -2.1 -0.1 3.4 -2.7 -7.1 -17.1 -0.4
Debt-ratio 98.7 95.9 96.6 97.1 90.7 100.9 96.6 106.2 114.2 122.8 98.6
Quick-ratio 88.4 132.1 107.9 109.4 132.0 80.8 107.9 107.8 96.8 87.6 107.1
reserve-ratio 1,791.4 1,869.3 1,910.0 1,856.9 1,830.3 1,831.4 1,910.0 1,918.6 1,962.9 2,013.3 1,872.6
EPS -1,329 2,494 2,080 1,082 -302 285 1,847 -1,804 -5,063 -14,213 6
BPS 52,457 54,882 60,000 55,780 56,600 57,411 60,000 59,509 59,930 60,354 58,380
Dividends 600 600 600 600
2021-06-10
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
Gap
(Indication /
stock)
Color
High price ~ 16 %
High mid ~ 0 %
Mid ~ -15 %
Low mid ~ -30 %
Low price ~ -45 %
Indication price Range Current stock price Company score
160,712 W 160,712 W 136,366 W
136,366 W 136,366 W 112,021 W Evaluation
185,057 W 185,057 W~ 160,712 W
160,000 W
42.7
112,021 W 112,021 W 87,675 W
High mid
Normal
87,675 W 87,675 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Pharmaceutical 79 18 3,129 1,561
87,675원
112,021원
136,366원
160,712원
185,057원
High mid 160,000원
-45%
-30%
-15%
.4%
15.7%
-50%
-40%
-30%
-20%
-10%
0.%
10.%
20.%
0W
20,000W
40,000W
60,000W
80,000W
100,000W
120,000W
140,000W
160,000W
180,000W
200,000W
Low price Low mid Mid High mid High
price
Indication price chart (Consolidated)
Indication price
daewoong pharmaceutical
Gap
daewoong pharmaceutical

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (consolidated) 069620 Date
Period
Gap
(Indication /
stock)
Color
2021-06-10
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
160,000 W High mid 32.3 Normal 2,500,000 W
Suggested Purchase
Amount 675,579 W
Number of stocks
purchased 4
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 185,057 W 185,057 W~ ~ 160,712 W 16 % -105,801 W -1
High mid 160,712 W 160,712 W ~ 136,366 W 0 % -3,006 W -0
Mid 136,366 W 136,366 W ~ 112,021 W -15 % 99,790 W 1
Low mid 112,021 W 112,021 W ~ 87,675 W -30 % 202,586 W 2
low price 87,675 W 87,675 W ~ 0 W -45 % 305,381 W 3
Stock price rise
probability score
A Sector 46.0 43.4 49.9 53.9 52.6 51.2
32.3
B Sector 16.7 19.6 20.4 53.9 28.8 40.0
Total average
2021.01.13 2021.02.10 2021.03.15 2021.04.12 2021.05.11 2021.06.09
31.3 31.5 35.2 12.5 40.7 45.6
69 % 11 %
2021.02.10 2021.03.15 2021.04.12 2021.05.11 2021.06.09
Total of
increase rate
Total score
A Sector -6 % 13 % 7 % -3 % -3 %
-18 % 52.3
B Sector 15 % 4 % 62 % -88 % 28 %
Total average 1 % 10 % -181 %
46 43
50
54 53 51
17
20 20
54
29
40
31 32
35
13
41
46
0
10
20
30
40
50
60
2021.01.13 2021.02.10 2021.03.15 2021.04.12 2021.05.11 2021.06.09
Stock price rise probability score
A sector
B sector
Total average
-6%
13% 7% -3% -3%
15% 4%
62%
-88%
28%
1% 10%
-181%
69%
11%
-200%
-150%
-100%
-50%
0%
50%
100%
2021.02.10 2021.03.15 2021.04.12 2021.05.11 2021.06.09
Increase rate of stock price rise
A sector
B sector
Total average
daewoong pharmaceutical

3. 정보와
완전
정보
결
투자판단
있습니
위배
무단으
숙지하
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374
①
Consulting is o
The Algorithm
accuracy or com
change over tim
results of the d
Consulting bec
②
information pr
investment dec
up
③
do anything th
transaction.
④
The Algorithm
information pr
⑤
analysis report